Age transition of cases, admissions, and deaths by COVID-19 in the municipality of Rio de Janeiro
DOI:
https://doi.org/10.20947/S0102-3098a0195Keywords:
Coronavirus infections, Pandemics, Epidemiology, VaccinesAbstract
Objective: To describe the evolution of cases, hospitalizations, and deaths from COVID-19 in the city of Rio de Janeiro by age group between March 2020 and April 2021. Methods: the relative frequencies of COVID-19 cases and deaths were calculated for ten-year age groups in the epidemiological week (EW) 13 from 2020 to 21 of 2021 and expected value ranges by age group and EW. Results: the higher burden of cases was concentrated in the 20-29 and 30-39 age groups. Hospitalizations and deaths were concentrated in the age groups 60-69 years, 70-79 years and 80 years or more, with a marked tendency to rejuvenate the burden of deaths from EW 10 of 2021. Conclusions: There is an age transition in the pandemic in Rio de Janeiro, possibly due to the progress of vaccination. This is, therefore, a successful measure. We insist on the need to accelerate the population immunization process for the control and prevention of COVID-19.
Downloads
References
BRASIL. Ministério da Saúde. Coronavírus Brasil: painel coronavírus. [Internet]. 2021a. Disponível em: https://covid.saude.gov.br/ Acesso em: 29 maio 2021.
BRASIL. Ministério da Saúde. Departamento de Informática do SUS. Informações de Saúde. [internet]. 2021b. Disponível em: http://www.datasus.gov.br Acesso em: 27 maio 2021.
FUNDAÇÃO OSWALDO CRUZ. Boletim Observatório Covid-19: semanas epidemiológicas 16 e 17 − de 18 de abril a 1º de maio de 2021. [Internet] 2021a. Disponível em: portal.fiocruz.br/observatorio-covid-19 Acesso em: 10 jul. 2021.
FUNDAÇÃO OSWALDO CRUZ. Boletim Observatório Covid-19: Semanas epidemiológicas 18 e 19 − de 2 de maio a 15 de maio de 2021. [Internet]. 2021b. Disponível em: portal.fiocruz.br/observatorio-covid-19 Acesso em: 10 jul. 2021.
FUNDAÇÃO OSWALDO CRUZ. Boletim Observatório Covid-19: semanas epidemiológicas 20 e 21 − de 16 a 29 de maio de 2021. [Internet]. 2021c. Disponível em: portal.fiocruz.br/observatorio-covid-19, Acesso em: 10 jul. 2021.
KRITSKI, A. et al. Panorama da COVID-19. [Internet]. Rio de janeiro: Universidade Federal do Rio de Janeiro, 2020. Disponível em: https://ufrj.br/sites/default/files/img-noticia/2020/03/notatecnica25032020.pdf Acesso em: 20 jun. 2021.
MONTGOMERY, D. C. Introduction to statistical quality control. New York: John Wiley & Sons, 2020.
NATIONAL RECORDS OF SCOTLAND. Deaths involving covid-19 week 6: 8 Feb-14. [Internet]. 2021. Disponível em: https://www.nrscotland.gov.uk/news/2021/deaths-involving-covid-19-week-6-8-feb-14-feb Acesso em: 27 maio 2021.
OMS − Organização Mundial da Saúde. Novel Coronavirus (2019-nCoV). Situation report. [Internet]. 2020. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/330988/nCoVsitrep08Feb2020-eng.pdf?sequence=1&isAllowed=y. Acesso em: 23 maio 2021.
RIO DE JANEIRO (Município). Secretaria Municipal de Saúde. Painel Rio COVID-19. [Internet]. 2021. Disponível em: https://experience.arcgis.com/experience/38efc69787a346959c931568bd9e2cc4 Acesso em: 30 maio 2021.
RITCHIE, H. et al. Coronavirus pandemic (COVID-19). Our world in data. [Internet]. 2020. Disponível em: https://ourworldindata.org/coronavirus Acesso em: 29 maio 2021.
ROSER, M.; RITCHIE, H.; ORTIZ-OSPINA, E.; HASELL, J. Our world in data: Coronavirus pandemic (COVID-19). 2020. Disponível em: https://ourworldindata.org/coronavirus Acesso em janeiro 2022.
ROSSMAN, H. et al. COVID-19 dynamics after a national immunization program in Israel. Nat Med, v. 27, p. 10551061, 2021.
SILVA, G. A.; JARDIM, B. C.; SANTOS, C. V. B. Excesso de mortalidade no Brasil em tempos de Covid-19. Ciência & Saúde Coletiva, v. 25, n. 9, p. 3345-54, 2020.
WISE, J. Covid-19: infections in England fall by two thirds since January. BMJ, v. 18, n. 372, p. 491, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Brasileira de Estudos de População
This work is licensed under a Creative Commons Attribution 4.0 International License.
Papers published in Rebep are original and protected under the Creative Commons attribution-type license (CC-BY). This license allows you to reuse publications in whole or in part for any purpose, free of charge, even for commercial purposes. Any person or institution can copy, distribute or reuse the content, as long as the author and the original source are properly mentioned.